FDA Clears Meningitis/Encephalitis Panel for Rapid, Syndromic Testing
QIAGEN’s Meningitis/Encephalitis Panel received FDA clearance, providing providers with rapid testing for meningitis and encephalitis.
Read MorePosted by Andy Lundin | Nov 4, 2024 | Infectious Diseases |
QIAGEN’s Meningitis/Encephalitis Panel received FDA clearance, providing providers with rapid testing for meningitis and encephalitis.
Read MorePosted by Andy Lundin | Nov 4, 2024 | Molecular Diagnostics |
Lurie Children’s Hospital aims to invest in optical genome mapping (OGM) for faster, precise brain tumor diagnosis in children
Read MorePosted by Andy Lundin | Nov 4, 2024 | Flu & Respiratory Infections |
QIAGEN’s QIAstat-Dx Respiratory Panel Mini provides fast and accurate diagnosis of upper respiratory infections in outpatient settings.
Read MorePosted by Chris Wolski | Nov 1, 2024 | Sepsis |
VolitionRx’s report demonstrated that the Nu.Q NETs sepsis test can predict patients who are at higher risk of deteriorating from sepsis.
Read MorePosted by Chris Wolski | Oct 30, 2024 | Immunoassay |
New England Biolabs is improving accessibility with a range of development tools, including shelf-stable reagents and enzyme-based tools.
Read More